
Nike’s Q4 revenue declined 1% and China sales fell double digits (Greater China -17% constant-currency), failing to reassure investors even as EPS rose to $0.72 helped by a $986M tariff-refund benefit. Management guided to further revenue declines through the first half of fiscal 2027 and said the turnaround remains “uneven,” with elevated inventory and stiff competition weighing on margins. Shares fell about 4% in extended trading before partially recovering, reinforcing risk from tariffs (previously projected ~$1.5B cost) and weak consumer demand in China.
The key issue is not the quarter, it is the bridge from here to normalized earnings: the current beat appears largely non-operating, while the core business is still being forced through inventory cleanup and channel reset. That usually means estimate cuts lag by 1-2 quarters, then the stock de-rates again when investors realize the turnaround is consuming margin before it creates durable top-line leverage. In the next 3-6 months, the market will likely focus less on headline EPS and more on whether gross margin can stay positive once the one-off tariff benefit rolls off.
The competitive read-through is more interesting than the print itself. China weakness plus assortment issues imply share transfer toward domestic brands, but the second-order effect is that those gains may be structural if Nike’s wholesale execution remains inconsistent; that argues for relative shorts against NKE rather than broad consumer longs. Adidas is a cleaner beneficiary outside China if retailer shelf space continues to rotate away from Nike, while ANTA and Li Ning can keep taking premium domestic share if local consumers stay cautious on U.S. brands.
The contrarian point is that the market may be underpricing how long this reset takes. A turnaround guided into fiscal 2027 is effectively an earnings deferral story, and deferred earnings usually compress the multiple before they rebuild it. The thesis breaks if China improves faster than expected or if the wholesale re-engagement drives sustained sell-through without inventory buildup; absent that, this is a 6-18 month story with downside concentrated in the next two quarters.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately negative
Sentiment Score
-0.55
Ticker Sentiment